RegulatoryOfficial

INFARMED updates list of medicines with temporarily suspended export, citing supply and quetiapine, estradiol concerns

🇵🇹 INFARMED · Thu 12 Nov 2026

Portugal's regulator has issued Deliberation 110/CD/2026, extending temporary export suspensions to protect supply of critical medicines, exceptional-use products, and all quetiapine oral solids and estradiol medicines.

INFARMED, the Portuguese medicines authority, has updated its list of medicines whose export is temporarily suspended. The change was made through Deliberation No. 110/CD/2026 and communicated in Circular Informativa No. 103/CD/100.20.200, dated 11 November 2026 and published on 12 November.

According to the authority, the suspension is intended to help normalise supply of critical medicines that were in shortage during October. It also covers medicines being supplied under exceptional use authorisation.

The measure further applies to all medicines containing quetiapine in solid oral forms, and to all medicines containing estradiol. INFARMED specifies that this covers products that are marketed as well as those that are temporarily unavailable.

The circular does not itemise individual products that were added to or removed from the list. The full list is available in electronic format on INFARMED's page for managing medicine availability.

What it means for your team

  • Marketing authorisation holders and wholesalers should check the electronic list on INFARMED's medicine availability page to see whether their products are covered before any export.
  • Companies holding quetiapine solid oral forms or estradiol-containing products should note that the suspension applies to all such medicines, whether marketed or temporarily unavailable.
  • Products supplied under exceptional use authorisation, and critical medicines that were short in October, are also within scope, so supply-chain and distribution plans may need review.

Official source: INFARMED ↗

Article written by VigiEye from the official source (INFARMED). AI-assisted; check the source before acting.

More Regulatory All →